<DOC>
	<DOCNO>NCT00741663</DOCNO>
	<brief_summary>The question whether sequential diuretic therapy , mean use antialdosteronic drug first add loop diuretic nonresponders , good combination two diuretic begin ( combine diuretic therapy ) treatment ascites patient cirrhosis still open . Therefore , aim study compare sequential versus combine diuretic therapy patient . One hundred patient randomize two group . Group A receive potassium canrenoate initial dose 200 mg/day , increase 400 mg/day . Non responder treat 400 mg/day potassium canrenoate furosemide initial dose 50 mg/day , increase 150 mg/day . Group B receive first 200 mg/day potassium canrenoate 50 mg/day furosemide , increase 400 mg/day 150 mg/day , respectively . The percentage responders dthe diuretic treatment , time get resolution ascites rate adverse effect compare two Groups Patients .</brief_summary>
	<brief_title>Spironolactone Versus Spironolactone Plus Furosemide ( SVSSF )</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Canrenoic Acid</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>Grade 2 ascites Serum creatinine le 1.2 mtg/dl Serum sodium &gt; 130 mmol/l Serum potassium within 3.5 4.5 mmol/l At least five day withdrawal diuretics A 90 mmol/day Na diet . Any therapeutic paracentesis ascites inclusion Cardiac respiratory disease Gastrointestinal bleeding , hepatic encephalopathy , bacterial infection last 4 week inclusion . The use NSAIDs nephrotoxic drug last 4 week inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>ascites</keyword>
	<keyword>diuretic therapy</keyword>
	<keyword>potassium canrenoate</keyword>
	<keyword>furosemide</keyword>
	<keyword>hyperkalemia</keyword>
	<keyword>plasma renin activity</keyword>
	<keyword>nitric oxide</keyword>
	<keyword>serum sodium concentration</keyword>
	<keyword>refractory ascites</keyword>
	<keyword>Nonazotemic patient cirrhosis moderate ascites</keyword>
</DOC>